Unipetrol AS (UNIPE):石油・ガス:M&Aディール及び事業提携情報

◆英語タイトル:Unipetrol AS (UNIPE) - Oil & Gas - Deals and Alliances Profile
◆商品コード:DATA904C8701
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:チェコ
◆産業分野:石油・ガス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Unipetrol AS (Unipetrol), a subsidiary of Polski Koncern Naftowy Orlen SA, is refinery and petrochemical company. The company produces and sells petroleum products, petrochemicals, plastics and specialty chemicals. Unipetrol owns and operates transport services, filling stations and carries out research and development activities. The company operates with its subsidiaries and joint ventures which produces and sells refining and petrochemical products; operates the company’s retail network; manufactures bitumen, lubricants, and other refinery products; and operates refinery complexes in Litvinov and Kralupy. The company serves customers in Czech Republic, Germany, Poland, Slovakia, Austria and Hungary. Unipetrol is headquartered in Praha, Czech Republic.

Unipetrol AS (UNIPE) – Oil & Gas – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Oil & Gas eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Unipetrol AS, Oil & Gas, Deals By Year, 2012 to YTD 2018 5
Unipetrol AS, Oil & Gas Deals By Type, 2012 to YTD 2018 6
Unipetrol AS, Oil & Gas, Deals By Region, 2012 to YTD 2018 7
Unipetrol AS, Oil & Gas, Deals By Sector, 2012 to YTD 2018 8
Unipetrol AS, Oil & Gas, Deals Summary, 2012 to YTD 2018 9
Unipetrol AS, Oil & Gas, Deal Details 10
Asset Transactions 10
Government of Czech Plans To Acquire Kralupy Refinery In Czech From Unipetrol 10
Acquisition 11
PKN Orlen Completes Acquisition Of Remaining 5.97% Stake In Unipetrol For US$188.5 Million 11
PKN Orlen Completes Acquisition Of Additional 31.04% Stake In Unipetrol For Approximately US$1.03 Billion 13
Unipetrol Completes Acquisition Of Remaining 32.445% Interest In Ceska Rafinerska From Eni For US$26.4 Million 15
Unipetrol Completes Acquisition Of 16.335% Stake In Ceska Rafinerska From Shell Overseas Investments For US$27.2 Million 16
Unipetrol AS – Key Competitors 18
Unipetrol AS – Key Employees 19
Unipetrol AS – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Joint Venture 21
Recent Developments 22
Other Significant Developments 22
Jun 26, 2018: Unipetrol Invests CZK 100 Million In Launching Aviation Fuel Production In Litvinov 22
May 24, 2018: After Regular Turnaround, Unipetrol’s Refinery In Kralupy Is Back In Full Operation 23
Mar 27, 2018: Unipetrol Fully Restores Operation Of Its Distribution Terminal 24
Mar 24, 2018: Unipetrol May Restore Operation Of Distribution Terminal In Coming Days 25
Mar 22, 2018: Extraordinary Event At Kralupy Nad Vltavou Road Terminal 26
Dec 28, 2017: Unipetrol Put First Part Of Partial Oxidation Unit Into Operation 27
New Contracts Announcements 28
Apr 20, 2017: Neste Jacobs To Perform Comprehensive Energy Study For Unipetrol’s Refinery Site In Czech Republic 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Unipetrol AS, Oil & Gas, Key Facts, 2017 2
Unipetrol AS, Oil & Gas, Deals Summary, 2012 to YTD 2018 2
Unipetrol AS, Oil & Gas, Deals By Year, 2012 to YTD 2018 5
Unipetrol AS, Oil & Gas Deals By Type, 2012 to YTD 2018 6
Unipetrol AS, Oil & Gas, Deals By Region, 2012 to YTD 2018 7
Unipetrol AS, Deals By Sector, 2012 to YTD 2018 8
Unipetrol AS, Oil & Gas, Deals Summary, 2012 to YTD 2018 9
Government of Czech Plans To Acquire Kralupy Refinery In Czech From Unipetrol 10
PKN Orlen Completes Acquisition Of Remaining 5.97% Stake In Unipetrol For US$188.5 Million 11
PKN Orlen Completes Acquisition Of Additional 31.04% Stake In Unipetrol For Approximately US$1.03 Billion 13
Unipetrol Completes Acquisition Of Remaining 32.445% Interest In Ceska Rafinerska From Eni For US$26.4 Million 15
Unipetrol Completes Acquisition Of 16.335% Stake In Ceska Rafinerska From Shell Overseas Investments For US$27.2 Million 16
Unipetrol AS, Key Competitors 18
Unipetrol AS, Key Employees 19
Unipetrol AS, Subsidiaries 20
Unipetrol AS, Joint Venture 21

List of Figures
Unipetrol AS, Oil & Gas, Deals by Type, 2012 to YTD 2018 2
Unipetrol AS, Oil & Gas, Deals By Year, 2012 to YTD 2018 2
Unipetrol AS, Oil & Gas, Deals By Region, 2012 to YTD 2018 2
Unipetrol AS, Oil & Gas, Deals By Sector, 2012 to YTD 2018 2
Unipetrol AS, Oil & Gas, Deals By Year, 2012 to YTD 2018 5
Unipetrol AS, Oil & Gas, Deals by Type, 2012 to YTD 2018 6
Unipetrol AS, Oil & Gas, Deals By Region, 2012 to YTD 2018 7
Unipetrol AS, Oil & Gas, Deals by Sector, 2012 to YTD 2018 8

★海外企業調査レポート[Unipetrol AS (UNIPE):石油・ガス:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • DPR Construction Inc:企業の戦略的SWOT分析
    DPR Construction Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Petrolia SE (PDR):企業の財務・戦略的SWOT分析
    Summary Petrolia SE (Petrolia), formerly Petrolia E&P Holdings SE is an oil and gas company that offers well technology solutions. The company operates through two segments such as exploration and production (E&P), and oil service segments. Its E&P’s segment seeks to maximise field potential through …
  • Pear Therapeutics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Pear Therapeutics Inc (Pear Therapeutics) develops software-based prescription digital therapeutics for the treatment of severe medical conditions and diseases. Its product pipeline includes reSET-O for treating opioid use disorder (OUD) in conjunction with opioid replacement therapy; Thrive …
  • Mateon Therapeutics Inc (MATN):企業の財務・戦略的SWOT分析
    Summary Mateon Therapeutics Inc (Mateon), formerly OXiGENE Inc is a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications. The company develops therapeutics to treat cancer and eye diseases; and anti-vascular drugs such as vascular disrupting age …
  • BioMarker Strategies LLC-医療機器分野:企業M&A・提携分析
    Summary BioMarker Strategies LLC (BioMarker Strategies) is a biotechnology company that develops tissue-based cancer diagnostic systems. The company offers cancer diagnostics system for predictive tests to targeted treatments for solid tumor malignancies. It also offers pathmap functional signaling …
  • Acadia Healthcare Company Inc:企業のM&A・事業提携・投資動向
    Acadia Healthcare Company Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Acadia Healthcare Company Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Corning Incorporated (GLW)-エネルギー分野:企業M&A・提携分析
    Summary Corning Incorporated (Corning) manufactures and sells ceramics, specialty glasses and related materials. The company’s product portfolio includes glass substrates, which find application in LCD televisions, computer monitors and laptops; optical fibers, cable, hardware and equipment for tele …
  • Roche Diagnostics International Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Roche Diagnostics International Ltd (Roche Diagnostics), a subsidiary of F. Hoffmann-La Roche Ltd, is a provider of diagnostic system solutions to clinics, laboratories and doctors’ offices. The company develops, produces and services instruments and software systems used in in vitro diagnos …
  • Canada Energy Partners Inc (CE):石油・ガス:M&Aディール及び事業提携情報
    Summary Canada Energy Partners Inc (Canada Energy) is a natural gas exploration and development company. The company concentrates on mid-stream supplying of water disposal services, development of a wellbore mining technology and energy or mineral exploring. It develops a wellbore mining technology …
  • First Abu Dhabi Bank PJSC (FAB):企業の財務・戦略的SWOT分析
    First Abu Dhabi Bank PJSC (FAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • CK Infrastructure Holdings Ltd (1038):企業の財務・戦略的SWOT分析
    CK Infrastructure Holdings Ltd (1038) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Control4 Corp (CTRL):企業の財務・戦略的SWOT分析
    Control4 Corp (CTRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Alector LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Alector LLC (Alector) is a biotechnology company that develops therapies for immune system to cure neurodegeneration and cancer. The company discovers and develops immune modulatory therapies for Alzheimer’s disease and other neurodegenerative disorders. It combines state-of-the-art antibody …
  • Gazprom Neft (SIBN):石油・ガス:M&Aディール及び事業提携情報
    Summary Gazprom Neft, a subsidiary of Gazprom, is an integrated oil and gas company. It explores for, develops, and produces crude oil and natural gas. The company operates in Khanty-Mansi and Yamalo-Nenets Autonomous Districts, and Tomsk, Omsk and Orenburg regions in Russia; and also has production …
  • Celdara Medical LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Celdara Medical LLC (Celdara Medical) is a biotechnology company that helps transform academic innovations into medicines to cure serious diseases. It provides pipeline development services, and has a pipeline of anti-inflammatory therapeutics, latent HIV elimination, idiopathic pulmonary fi …
  • Enanta Pharmaceuticals Inc (ENTA):企業の財務・戦略的SWOT分析
    Summary Enanta Pharmaceuticals Inc (Enanta) is a biotechnology company that discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. The company’s lead product candidate includes EDP-305, a farnesoid X receptor (FXR) agonist intended for the treatment of …
  • Mapletree Investments Pte Ltd:企業の戦略的SWOT分析
    Mapletree Investments Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Seminole Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Seminole Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Dril-Quip Inc (DRQ):企業の財務・戦略的SWOT分析
    Dril-Quip Inc (DRQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Vect-Horus SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Vect-Horus SAS (Vect-Horus) is a biotechnology company that designs and develops peptide-based vectors to facilitate the delivery of drugs or imaging agents into organs including the brain and tumors. The company combines molecules of interest to peptide-vectors that targets receptor mediate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆